In the recent ten years, UBQLN1 is found to participate in neurodegenerative disease development, such as Alzheimer’s disease (AD), by regulating the maturation of full-length amyloid precursor protein (APP) [17,18]. This evidence concerns the gene APP and neurodegenerative disease.